Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6700
-0.0100 (-1.47%)
Feb 5, 2026, 3:52 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 231.47 million as of February 5, 2026. Its market cap has decreased by -13.40% in one year.
Market Cap
231.47M
Enterprise Value
216.89M
Revenue
79.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 231.47M, a decrease of -42.86%. That is a compound annual growth rate of -9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 231.47M | -9.34% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 837.17M |
| PolyNovo | 683.93M |
| Lumos Diagnostics Holdings | 213.96M |
| EMVision Medical Devices | 168.22M |
| SomnoMed | 141.99M |
| Cleo Diagnostics | 91.70M |
| Compumedics | 76.91M |
| Micro-X | 62.44M |